Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

NIAID Omnibus Broad Agency Announcement

Active
HHS-NIH-NIAID-BAA2017-1Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

N/A

Contract Value

$0

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

4 updates
PhasePresolicitation
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Type Changed

Presolicitation → Solicitation

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
George W KennedyContracting Officer

Full Description

Show more
Notes to Offerors: Note 1: THIS BROAD AGENCY ANNOUNCEMENT INCLUDES DISTINCT RESEARCH AREAS, EACH WITH A SPECIFIED CLOSING DATE AND TIME IDENTIFIED IN THE ATTACHED SOLICITATION. AN OFFEROR MUST SUBMIT A SEPARATE AND DISTINCT PROPOSAL FOR EACH RESEARCH AREA TO WHICH IT WISHES TO PROPOSE, IN ACCORDANCE WITH THE PROPOSAL SUBMISSION INSTRUCTIONS CONTAINED THEREIN. Note 2: Division of Allergy, Immunology, and Transplantation DAIT), NIAID, NIH Research Area 001: Adjuvant Development Program The inclusion of HIV envelope immunogen electives is no longer identified for this Research Area. The amended synopsis summary for Research Area 001 is as follows: DIVISION OF ALLERGY, IMMUNOLOGY, AND TRANSPLANTATION (DAIT), NIAID, NIH Research Area 001: Adjuvant Development Program This Research Area is intended to advance novel adjuvants towards licensure for human use through immunological characterization studies and lead compound optimization, up to and including IND-enabling studies. NIAID estimates up to five (5) contracts may be issued. The average annual total cost (direct and indirect costs combined) will be approximately $2.0M per award. While the total proposed costs and the length of time for which funding is requested should be consistent with the nature and complexity of the proposed research, the total performance period proposed by an offeror should not exceed five (5) years.

Similar Contracts

Same NAICS industry code

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS